Oxandrolone and Propranolol

Small molecule

TThe University of Texas Medical Branch, Galveston

Oxandrolone and Propranolol is one of 29 small molecule programs targeting Wound Healing. It is currently in development.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Wound HealingActive, not recruiting

Wound HealingPhase 2/Phase 3

Active, not recruiting

Competition

Competitive Landscape

133 competitors in Wound Healing

#DrugCompanyPhaseTrials

Januvia

ZZydus Therapeutics Inc.

Phase 3

1 2

Avastin

BBio-Thera Solutions

Phase 3

1 3

Glucophage

EMD Serono

Phase 3

1 4

Inderal

WWyeth-Lederle Vaccines

Phase 3

1 5

Growth Hormone

Pfizer

Phase 3

1 6

Vaseline

MMassachusetts General Hospital

Phase 3

1 7

Oxandrolone

PPar Pharmaceutical, Inc.

Phase 3

1 8

Becaplermin

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 3

1 9

Nicorette

Pfizer

Preclinical

1 10

Zofran

Novartis

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Wound Healing1 trial

Assessment of Mechanisms of Improved Wound Healing

Completed·TThe University of Texas Medical Branch, Galveston·Phase 2/3·NCT00673309·644 enrolled

Rehabilitation1 trial

Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation

Terminated·TThe University of Texas Medical Branch, Galveston·Phase 2/3·NCT00675714·1,126 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Oxandrolone and Propranolol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Oxandrolone and Propranolol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Oxandrolone and Propranolol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — The University of Texas Medical Branch, Galveston company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Company: TThe University of Texas Medical Branch, Galveston

Oxandrolone and Propranolol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Wound Healing1 trial

Rehabilitation1 trial

References

Drug Info

Quick Facts

Related News